Related Experiment Video
Updated: Sep 19, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA
Published on: February 9, 2011
Hypersensitivity reactions to non-betalactam antibiotics in children: an extensive review
Semanur Kuyucu1, Francesca Mori, Marina Atanaskovic-Markovic
1Department of Pediatric Allergy and Immunology, Mersin University, Faculty of Medicine, Mersin, Turkey.
Insights
Hypersensitivity reactions (HSRs) to non-β-lactam antibiotics (NBLAs) in children are poorly understood, with limited diagnostic tools. Standardized approaches are needed for evaluating these critical reactions.
Area of Science:
- Pediatric Allergy and Immunology
- Pharmacology and Therapeutics
Background:
- Hypersensitivity reactions (HSRs) to non-β-lactam antibiotics (NBLAs) in children are under-researched, with data primarily from case reports.
- NBLAs can cause a broad range of HSRs, from mild rashes to severe, potentially fatal systemic reactions, particularly in high-risk pediatric populations.
Purpose of the Study:
- To review and synthesize current knowledge on the clinical characteristics, diagnostic evaluation, and management of HSRs to NBLAs in children.
- To highlight the challenges in diagnosing NBLA hypersensitivity due to limitations in current testing methodologies.
Main Methods:
- Extensive literature review of studies published between 1980 and 2013.
- Analysis of clinical characteristics, diagnostic approaches (history, skin tests, provocation tests), and management strategies for NBLA-induced HSRs in pediatric patients.
Main Results:
- Diagnosis of NBLA-induced HSRs heavily relies on patient history, as allergological tests often remain unconfirmed.
- Validated in vivo and in vitro diagnostic tests for NBLAs are lacking, making definitive diagnosis challenging.
- Confirmed HSRs to NBLAs in children ranged from 7.8% to 36% when assessed by skin and/or provocation tests.
Conclusions:
- A significant proportion of suspected HSRs to NBLAs in children are not confirmed by objective testing.
- There is a critical need for standardized diagnostic approaches and management strategies for pediatric patients experiencing suspected HSRs to NBLAs.
- Developing such strategies is essential, especially given the importance of some NBLAs in pediatric treatment regimens.
Abstract:
In contrast to hypersensitivity reactions (HSRs) to β-lactam antibiotics in children, studies about HSR to non-β-lactam antibiotics (NBLAs) such as sulfonamides, macrolides, quinolones, and antituberculosis agents are scarce, and information is generally limited to case reports. The aim of this extensive review was to summarize our present knowledge on clinical characteristics, evaluation, and management of HSR to NBLAs in children based on the literature published between 1980 and 2013. NBLAs have been reported to induce a wide spectrum of HSRs from mild eruptions to severe, and sometimes fatal, systemic drug reactions, especially in some high-risk groups. The diagnosis relied upon history and remained unconfirmed by allergological tests in most of the cases. Obtaining a detailed history is valuable in the diagnosis of suspected reactions to NBLAs. Diagnostic in vivo and in vitro tests for NBLAs lack validation, which makes the diagnosis challenging. The definitive diagnosis of NBLA hypersensitivity frequently depends upon drug provocation tests. Studies including children showed that only 7.8 to 36% of suspected immediate and delayed HSRs to NBLAs could be confirmed by skin and/or provocation tests. Therefore, a standardized diagnostic approach and management strategy should be developed and employed for pediatric patients in the evaluation of suspected HSRs to NBLAs, some of which may be critical and unreplaceable in certain clinical situations.
Related Concept Videos
Allergic Drug Reactions
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Excretion
Drug Toxicity: Allergic Reactions
Allergic Reactions: Anaphylaxis
Hypersensitivity Reactions: Cytolytic Reactions

